Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
Koen W. Streng, Jan F. Nauta, Hans L. Hillege, et al.
International Journal of Cardiology (2018) Vol. 271, pp. 132-139
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Global burden of heart failure: a comprehensive and updated review of epidemiology
Gianluigi Savarese, Peter Moritz Becher, Lars H. Lund, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3272-3287
Open Access | Times Cited: 1478
Epidemiology of heart failure
Amy Groenewegen, Frans H. Rutten, Arend Mosterd, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1342-1356
Open Access | Times Cited: 1444
Heart failure with mid-range or mildly reduced ejection fraction
Gianluigi Savarese, Davide Stolfo, Gianfranco Sinagra, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 2, pp. 100-116
Open Access | Times Cited: 300
Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
Steven J. Simmonds, Ilona Cuijpers, Stéphane Heymans, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 242-242
Open Access | Times Cited: 277
SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
Carolyn S.P. Lam, Chanchal Chandramouli, Vineeta Ahooja, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 20
Open Access | Times Cited: 153
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Mark Sweeney, Ben Corden, Stuart A. Cook
EMBO Molecular Medicine (2020) Vol. 12, Iss. 10
Open Access | Times Cited: 153
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker, Muhammad Usman, Markus S. Anker, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 936-955
Open Access | Times Cited: 75
Trends in prevalence of comorbidities in heart failure clinical trials
Muhammad Shahzeb Khan, Ayman Samman Tahhan, Muthiah Vaduganathan, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 6, pp. 1032-1042
Open Access | Times Cited: 109
Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science
Alessia Lena, Markus S. Anker, Jochen Springer
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6549-6549
Open Access | Times Cited: 100
Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers
Filippos Triposkiadis, Αndrew Xanthopoulos, John Parissis, et al.
Heart Failure Reviews (2020) Vol. 27, Iss. 1, pp. 337-344
Closed Access | Times Cited: 94
Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Thássio Mesquita, Yen‐Nien Lin, Ahmed Ibrahim
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 57
Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study
Shunsuke Tamaki, Yoshiyuki Nagai, Ryu Shutta, et al.
Journal of the American Heart Association (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 49
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan
Masaru Obokata, Hidemi Sorimachi, Tomonari Harada, et al.
Journal of Cardiac Failure (2023) Vol. 29, Iss. 3, pp. 375-388
Open Access | Times Cited: 32
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry
Ovidiu Chioncel, Lina Benson, María G. Crespo‐Leiro, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 13, pp. 1346-1358
Closed Access | Times Cited: 22
Non‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial
Ovidiu Chioncel, Beth A. Davison, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1994-2006
Open Access | Times Cited: 22
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
Seyedmohammad Saadatagah, Mohammadreza Naderian, Md Mesbah Uddin, et al.
JAMA Cardiology (2024) Vol. 9, Iss. 6, pp. 497-497
Closed Access | Times Cited: 9
Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial
Frank Edelmann, Rolf Wachter, André Duvinage, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
Alexander Fuerlinger, Alina Stockner, Simon Sedej, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Sex and clinical outcomes in new-onset heart failure
Lourdes Vicent, MaDolores García-Cosio, José Seijas‐Amigo, et al.
International Journal of Cardiology (2025), pp. 133092-133092
Closed Access | Times Cited: 1
Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
Jens van de Wouw, Michelle Broekhuizen, Oana Sorop, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 67
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum
Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
International Journal of Cardiology (2019) Vol. 298, pp. 59-65
Closed Access | Times Cited: 59
Quality of life among patients with cardiac disease: the impact of comorbid depression
Mandreker Bahall, George Legall, Katija Khan
Health and Quality of Life Outcomes (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Estimated plasma volume status in heart failure: clinical implications and future directions
Masatake Kobayashi, Nicolas Girerd, Kévin Duarte, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 8, pp. 1159-1172
Closed Access | Times Cited: 41
Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure Spectrum
Nicola Riccardo Pugliese, Alessio Balletti, Silvia Armenia, et al.
JACC. Cardiovascular imaging (2022) Vol. 15, Iss. 9, pp. 1545-1559
Open Access | Times Cited: 30
Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study
Teresa Gerhardt, Louisa M.S. Gerhardt, Wouter Ouwerkerk, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 12, pp. e1874-e1884
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top